摘要
目的分析不同剂量rh G-CSF预防晚期非小细胞肺癌化疗后白细胞减少的临床研究。方法方便择取该院2012年1月—2015年1月收治的晚期非小细胞肺癌化疗患者90例,分为每组患者均占据30例的a组、b组、c组,均给予不同剂量的rh G-CSF进行治疗。结果 a组数据白细胞水平低于4.0×109个/L的人数相比b组、c组差异有统计学意义,P<0.05;比较三组患者白细胞回升至4.0×109个/L的时间差异有统计学意义,P<0.05。结论对晚期非小细胞肺癌患者选择剂量较大的rh G-CSF将有效缩短白细胞与中性粒细胞水平的回升时间。
Objective To analyze different doses rhG CSF - prevention of advanced non-small cell lung cancer after chemotherapy leukopenia clinical studies. Methods Will pick our hospital in January 2012 - January 2015 90 cases of ad-vanced non-small cell lung cancer chemotherapy patients, divided into occupy 30 cases for each group of patients in group a, group b and group c, were given different doses of rhG CSF for treatment. Results A set of data leucocyte level below 4.0 x 10^9/ L group c compared with group b, the number of significant difference, P﹤ 0.05; Compare three groups of patients with white blood cells recovered to 4.0 x 10^9/L time significant difference, P﹤0.05. Conclusion In patients with advanced non-small cell lung cancer choose larger rhG CSF will effectively shorten the recovery time of white blood cells and neu-trophils.
出处
《中外医疗》
2016年第18期119-120,共2页
China & Foreign Medical Treatment
